We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+2.71%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$10.1B
AUM Growth
+$137M
Cap. Flow
+$105M
Cap. Flow %
1.04%
Top 10 Hldgs %
27.88%
Holding
173
New
17
Increased
64
Reduced
61
Closed
5

Top Buys

Rank Stock Value
1
AMED
Amedisys
AMED
+$92.7M
2
PGNY icon
Progyny
PGNY
+$45.5M
3
PRVA icon
Privia Health
PRVA
+$44.6M
4
SQSP
Squarespace, Inc.
SQSP
+$42.6M
5
TDUP icon
ThredUp
TDUP
+$40.4M

Sector Composition

Rank Sector Weight
1 Technology 38.01%
2 Healthcare 23%
3 Industrials 15.49%
4 Consumer Discretionary 8.61%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
51
Ecolab
ECL
$79.8B
$66.2M 0.65%
282,124
-117,004
-29% -$26.4M
MEDP icon
52
Medpace
MEDP
$16.3B
$66.2M 0.65%
304,021
+11,340
+4% +$2.37M
KIDS icon
53
OrthoPediatrics
KIDS
$513M
$66.2M 0.65%
1,105,273
+34,358
+3% +$2.14M
CRL icon
54
Charles River Laboratories
CRL
$11.3B
$64.4M 0.64%
170,838
+5,553
+3% +$2.16M
POWI icon
55
Power Integrations
POWI
$3.15B
$63M 0.62%
678,734
+25,254
+4% +$2.48M
HCSG icon
56
Healthcare Services Group
HCSG
$1.61B
$61.3M 0.61%
3,447,345
-1,848,136
-35% -$35.9M
DSGX icon
57
Descartes Systems
DSGX
$6.68B
$60.2M 0.59%
727,531
+39,514
+6% +$3.24M
HSKA
58
DELISTED
Heska Corp
HSKA
$55.9M 0.55%
306,320
+12,323
+4% +$2.45M
OLLI icon
59
Ollie's Bargain Outlet
OLLI
$4.31B
$54.7M 0.54%
1,069,287
-15,680
-1% -$955K
KAI icon
60
Kadant
KAI
$3.58B
$54.3M 0.54%
235,462
+8,701
+4% +$1.94M
CHE icon
61
Chemed
CHE
$7.16B
$52.6M 0.52%
99,341
+3,395
+4% +$1.63M
FND icon
62
Floor & Decor
FND
$6.03B
$52M 0.51%
400,304
-41,343
-9% -$5.33M
GSHD icon
63
Goosehead Insurance
GSHD
$1.68B
$51.7M 0.51%
397,136
+15,793
+4% +$2.27M
GOOG icon
64
Alphabet (Google) Class C
GOOG
$4.11T
$51.4M 0.51%
355,040
-11,220
-3% -$1.62M
FRPT icon
65
Freshpet
FRPT
$3.04B
$51M 0.5%
535,013
+19,672
+4% +$2.44M
EYE icon
66
National Vision
EYE
$1.76B
$50M 0.49%
1,041,800
+38,682
+4% +$2.07M
V icon
67
Visa
V
$701B
$49.6M 0.49%
228,839
-6,918
-3% -$1.49M
OSH
68
DELISTED
Oak Street Health, Inc.
OSH
$49.6M 0.49%
1,496,198
-149,087
-9% -$5.64M
NFLX icon
69
Netflix
NFLX
$307B
$48.2M 0.48%
799,710
-23,370
-3% -$1.49M
GNTX icon
70
Gentex
GNTX
$5.1B
$48.2M 0.48%
1,382,004
-2,574,550
-65% -$91.3M
PRVA icon
71
Privia Health
PRVA
$3.04B
$46.3M 0.46%
+1,788,592
New +$44.6M
WSO icon
72
Watsco Inc
WSO
$13.2B
$45.8M 0.45%
146,327
+2,669
+2% +$791K
PRAA icon
73
PRA Group
PRAA
$672M
$45.8M 0.45%
911,684
+32,531
+4% +$1.45M
CGNX icon
74
Cognex
CGNX
$9.62B
$44.4M 0.44%
571,341
+18,628
+3% +$1.5M
HCAT icon
75
Health Catalyst
HCAT
$160M
$44.1M 0.44%
1,113,456
+40,825
+4% +$1.86M

Similar funds

Riverbridge Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Riverbridge Partners held 173 positions worth $10.1B, up 1.4% from $9.97B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Riverbridge Partners's Q4 2021 filing shows 17 new, 64 increased, 61 reduced and 5 closed positions. Its largest new stake was Progyny: 812,333 shares worth $40.9M. The largest sale was Gentex, an estimated $91.3M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.

  • Riverbridge Partners's largest Q4 2021 buy was Progyny: 812,333 shares worth $40.9M.
  • Riverbridge Partners added most to Amedisys in Q4 2021, an estimated $92.7M increase.
  • Riverbridge Partners's biggest Q4 2021 reduction was Gentex, cutting an estimated $91.3M.
  • Riverbridge Partners fully exited Maximus in Q4 2021, selling an estimated $39.6M.
  • Riverbridge Partners's ten largest holdings make up 28% of its $10.1B portfolio in Q4 2021.
  • Riverbridge Partners opened 17 new positions and closed 5 in Q4 2021.
  • Riverbridge Partners's portfolio value rose 1.4% quarter-over-quarter to $10.1B.

Based on Riverbridge Partners's 13F filing for Q4 2021, filed 14 Jan 2022.